LPTX stock forecast
Our latest prediction for Leap Therapeutics, Inc.'s stock price was made on the Nov. 14, 2017 when the stock price was at 5.98$.
In the short term (2weeks), LPTX's stock price should outperform the market by 3.22%. During that period the price should oscillate between -7.96% and +12.72%.
In the medium term (3months), LPTX's stock price should outperform the market by 3.37%. During that period the price should oscillate between -18.10% and +31.45%.Get email alerts
About Leap Therapeutics, Inc.
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01 and TRX518. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.35$ per share.
The book value per share is 0.83$
Three months stock forecastNov. 14, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|